UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion?

Pain (Amsterdam), 2008-08, Vol.138 (2), p.343-353

2008

Volltextzugriff (PDF)

Chronic cluster headache: a French clinical descriptive study

Journal of neurology, neurosurgery and psychiatry, 2007-12, Vol.78 (12), p.1354-1358

2007

Volltextzugriff (PDF)

One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study

Journal of headache and pain, 2023-11, Vol.24 (1), p.152-152, Article 152

2023

Volltextzugriff (PDF)

Neurostimulation methods in the treatment of chronic pain

Journal of Neural Transmission, 2020-04, Vol.127 (4), p.673-686

2020

Volltextzugriff (PDF)

Prevalence and clinical characteristics of migraine in France

Neurology, 2002-07, Vol.59 (2), p.232-237

2002

Volltextzugriff (PDF)

Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day)

Journal of headache and pain, 2011-04, Vol.12 (2), p.173-176

2011

Volltextzugriff (PDF)

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)

Journal of headache and pain, 2012-07, Vol.13 (5), p.361-378

2012

Volltextzugriff (PDF)

Démarche diagnostique générale devant une céphalée chronique quotidienne (CCQ) — Prise en charge d’une CCQ chez le migraineux : céphalée par abus médicamenteux et migraine chronique. Recommandations de la SFEMC, de l’ANLLF et de la SFETD

Douleur et analgésie, 2014-09, Vol.27 (3), p.163-180

2014

Volltextzugriff (PDF)

Recommendations for headache service organisation and delivery in Europe

Journal of headache and pain, 2011-08, Vol.12 (4), p.419-426

2011

Volltextzugriff (PDF)

Clinical determinants of migraine preventive treatment: Contribution of SMILE, an observational survey of primary care migraine management in France

Cephalalgia, 2010-10, Vol.30 (10), p.1207-1213

2010

Volltextzugriff (PDF)

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)

Pain (Amsterdam), 2005-03, Vol.114 (1), p.29-36

2005

Volltextzugriff (PDF)

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy

International journal of clinical practice (Esher), 2010-06, Vol.64 (7), p.936-943

2010

Volltextzugriff (PDF)

The Eurolight project: the impact of primary headache disorders in Europe. Description of methods

Journal of headache and pain, 2011-10, Vol.12 (5), p.541-549

2011

Volltextzugriff (PDF)

Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management

Pain (Amsterdam), 2005-12, Vol.118 (3), p.319-326

2005

Volltextzugriff (PDF)

Prevalence and description of chronic daily headache in the general population in France

Pain (Amsterdam), 2003-03, Vol.102 (1), p.143-149

2003

Volltextzugriff (PDF)

Douleur en France : l’implication en 2011–2012 des autorités sanitaires en partenariat avec la Société française d’étude et traitement de la douleur

Douleur et analgésie, 2012-12, Vol.25 (4-5), p.219-223

Lanteri-Minet, M.

2012

Volltextzugriff (PDF)

Pain assessment in Charcot-Marie-Tooth (CMT) disease

Annals of physical and rehabilitation medicine, 2012-04, Vol.55 (3), p.160-173

2012

Volltextzugriff (PDF)

Traitements pharmacologiques actuels, recommandations et perspectives

Douleur et analgésie, 2010-06, Vol.23 (2), p.93-98

2010

Volltextzugriff (PDF)

The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research

Journal of headache and pain, 2018-02, Vol.19 (1), p.12-5, Article 12

2018

Volltextzugriff (PDF)

What Do Patients Want from Their Acute Migraine Therapy?

European Neurology, 2005-01, Vol.53 (Suppl 1), p.3-9

Lantéri-Minet, Michel

2005

Volltextzugriff (PDF)

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial

Lancet neurology, 2007-12, Vol.6 (12), p.1054-1062

2007

Volltextzugriff (PDF)

Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

Lancet neurology, 2012-05, Vol.11 (5), p.405-413

2012

Volltextzugriff (PDF)

French guidelines for the diagnosis and management of migraine in adults and children

Clinical therapeutics, 2004-08, Vol.26 (8), p.1305-1318

2004

Volltextzugriff (PDF)

Sécurité d’emploi de l’ibuprofène en prescription médicale facultative chez l’adulte : méta-analyse comparative ibuprofène versus placebo et paracétamol

Douleur et analgésie, 2015-06, Vol.28 (2), p.100-115

2015

Volltextzugriff (PDF)

Nouveautés et perspectives dans le traitement de la migraine

Douleur et analgésie, 2010-09, Vol.23 (3), p.166-174

Lantéri-Minet, M.

2010

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieComptes Rendus De L'académie Des Sciences, Série Iii, Sciences De La Vie

ThemaNeurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(33)
Bücher
(1)

Sprache

Englisch
(27)
Französisch
(7)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion?

Chronic cluster headache: a French clinical descriptive study

One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry study

Neurostimulation methods in the treatment of chronic pain

Prevalence and clinical characteristics of migraine in France

Cardiac safety in cluster headache patients using the very high dose of verapamil (≥720 mg/day)

Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)

Démarche diagnostique générale devant une céphalée chronique quotidienne (CCQ) — Prise en charge d’une CCQ chez le migraineux : céphalée par abus médicamenteux et migraine chronique. Recommandations de la SFEMC, de l’ANLLF et de la SFETD

Recommendations for headache service organisation and delivery in Europe

Clinical determinants of migraine preventive treatment: Contribution of SMILE, an observational survey of primary care migraine management in France

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)

Efficacy of almotriptan in early intervention for treatment of acute migraine in a primary care setting: the STARTstudy

The Eurolight project: the impact of primary headache disorders in Europe. Description of methods

Anxiety and depression associated with migraine: Influence on migraine subjects' disability and quality of life, and acute migraine management

Prevalence and description of chronic daily headache in the general population in France

Douleur en France : l’implication en 2011–2012 des autorités sanitaires en partenariat avec la Société française d’étude et traitement de la douleur

Pain assessment in Charcot-Marie-Tooth (CMT) disease

Traitements pharmacologiques actuels, recommandations et perspectives

The Headache-Attributed Lost Time (HALT) Indices: measures of burden for clinical management and population-based research

What Do Patients Want from Their Acute Migraine Therapy?

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial

Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

French guidelines for the diagnosis and management of migraine in adults and children

Sécurité d’emploi de l’ibuprofène en prescription médicale facultative chez l’adulte : méta-analyse comparative ibuprofène versus placebo et paracétamol

Nouveautés et perspectives dans le traitement de la migraine

Aktive Filter

Suchergebnisse filtern